Received Jun 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 2 | F4AC3 | IM / LA |
Patient received a second dose of a one-dose series. The first dose was administered to the patient in August of 2023, but not reported to the State Immunization Registry. The second dose was administered on June 6, 2025. Patient reports no adverse effects following the second dose.